Gabelli Funds’s Intersect ENT, Inc XENT Stock Holding History

Gabelli Funds’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-307,884	Closed	-$8.62M	–	1466
2022 Q1	$8.62M	Buy	307,884 +75,202	+32%	+$2.06M	0.06%	375
2021 Q4	$6.36M	Buy	232,682 +52,428	+29%	+$1.42M	0.04%	450
2021 Q3	$4.9M	Buy	180,254 +164,843	+1,070%	+$4.08M	0.03%	510
2021 Q2	$263K	Sell	15,411 -89	-0.6%	-$1.67K	﹤0.01%	1174
2021 Q1	$324K	Sell	15,500 -11,000	-42%	-$254K	﹤0.01%	1129
2020 Q4	$607K	Sell	26,500 -14,198	-35%	-$270K	﹤0.01%	961
2020 Q3	$664K	Buy	+40,698	New	+$737K	0.01%	893

Gabelli Funds's XENT Position: Q2 2022 in Review

Gabelli Funds sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 307,884 shares — an estimated $8.62M sold.

Gabelli Funds first reported a position in XENT in Q3 2020 and held it in 7 quarters. The position peaked at $8.62M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Gabelli Funds reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Gabelli Funds sold 307,884 Intersect ENT, Inc shares in Q2 2022, an estimated $8.62M.
Gabelli Funds first reported a position in Intersect ENT, Inc in Q3 2020 and held it in 7 quarters.
Gabelli Funds's Intersect ENT, Inc position peaked at $8.62M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Gabelli Funds's 13F filing for Q2 2022, filed 12 Aug 2022.